Oxidative stress impairs multiple regulatory events to drive persistent cytokine-stimulated STAT3 phosphorylation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 3, 2014, Pages 483-494

  Ng, Ivan H W ^a,b   Yeap, Yvonne Y C ^a   Ong, Lynette S R ^a,c   Jans, David A ^b   Bogoyevitch, Marie A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cytokines; Nuclear transport; Oxidative stress; STAT3

Indexed keywords

HYDROGEN PEROXIDE; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN;

ARTICLE; CELL LYSATE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; FIBROBLASTS; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-6; JANUS KINASES; LEUKEMIA INHIBITORY FACTOR; MICE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84891591821     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.11.015     Document Type: Article

References (60)

1. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
2. Mertens C., Darnell J.E. SnapShot: JAK-STAT signaling. Cell 2007, 131:612.
3. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 2002, 3:651-662.
4. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374:1-20.
5. Poli V. STAT3 function in vivo. Signal Transducers and Activators of Transcription (STATs) 2003, 492-512. Kluwer Academic Publishers, The Netherlands. P.B. Sehgal, D.E. Levy, T. Hirano (Eds.).
6. Yu H., Jove R. The STATs of cancer-new molecular targets come of age. Nat. Rev. Cancer 2004, 4:97-105.
7. Garcia R., Bowman T.L., Niu G., Yu H., Minton S., Muro-Cacho C.A., Cox C.E., Falcone R., Fairclough R., Parsons S., Laudano A., Gazit A., Levitzki A., Kraker A., Jove R. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001, 20:2499-2513.
8. Mustelin T., Vang T., Bottini N. Protein tyrosine phosphatases and the immune response. Nat. Rev. Immunol. 2005, 5:43-57.
9. Xu D., Qu C.K. Protein tyrosine phosphatases in the JAK/STAT pathway. Front. Biosci. 2008, 13:4925-4932.
10. Vinkemeier U. Getting the message across, STAT! Design principles of a molecular signaling circuit. J. Cell Biol. 2004, 167:197-201.
11. Babon J.J., Nicola N.A. The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factors 2012, 30:207-219.
12. Khaper N., Bryan S., Dhingra S., Singal R., Bajaj A., Pathak C.M., Singal P.K. Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. Antioxid. Redox Signal. 2010, 13:1033-1049.
13. Sena L.A., Chandel N.S. Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 2012, 48:158-167.
14. Zgheib C., Kurdi M., Zouein F.A., Gunter B.W., Stanley B.A., Zgheib J., Romero D.G., King S.B., Paolocci N., Booz G.W. Acyloxy nitroso compounds inhibit LIF signaling in endothelial cells and cardiac myocytes: evidence that STAT3 signaling is redox-sensitive. PLoS One 2012, 7:e43313.
15. Park S.K., Dahmer M.K., Quasney M.W. MAPK and JAK-STAT signaling pathways are involved in the oxidative stress-induced decrease in expression of surfactant protein genes. Cell. Physiol. Biochem. 2012, 30:334-346.
16. Millonig G., Ganzleben I., Peccerella T., Casanovas G., Brodziak-Jarosz L., Breitkopf-Heinlein K., Dick T.P., Seitz H.K., Muckenthaler M.U., Mueller S. Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). J. Biol. Chem. 2012, 287:37472-37482.
17. Szczepankiewicz B.G., Kosogof C., Nelson L.T., Liu G., Liu B., Zhao H., Serby M.D., Xin Z., Liu M., Gum R.J., Haasch D.L., Wang S., Clampit J.E., Johnson E.F., Lubben T.H., Stashko M.A., Olejniczak E.T., Sun C., Dorwin S.A., Haskins K., Abad-Zapatero C., Fry E.H., Hutchins C.W., Sham H.L., Rondinone C.M., Trevillyan J.M. Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity. J. Med. Chem. 2006, 49:3563-3580.
18. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 1998, 273:18623-18632.
19. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995, 364:229-233.
20. Thompson J.E., Cubbon R.M., Cummings R.T., Wicker L.S., Frankshun R., Cunningham B.R., Cameron P.M., Meinke P.T., Liverton N., Weng Y., DeMartino J.A. Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg. Med. Chem. Lett. 2002, 12:1219-1223.
21. Blake R.A., Broome M.A., Liu X., Wu J., Gishizky M., Sun L., Courtneidge S.A. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 2000, 20:9018-9027.
22. Schust J., Sperl B., Hollis A., Mayer T.U., Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 2006, 13:1235-1242.
23. Morris M.C., Deshayes S., Heitz F., Divita G. Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol. Cell 2008, 100:201-217.
24. Morris M.C., Depollier J., Mery J., Heitz F., Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 2001, 19:1173-1176.
25. Lam M.H., Michell B.J., Fodero-Tavoletti M.T., Kemp B.E., Tonks N.K., Tiganis T. Cellular stress regulates the nucleocytoplasmic distribution of the protein-tyrosine phosphatase TCPTP. J. Biol. Chem. 2001, 276:37700-37707.
26. Lam M.H., Henderson B., Gillespie M.T., Jans D.A. Dynamics of leptomycin B-sensitive nucleocytoplasmic flux of parathyroid hormone-related protein. Traffic 2001, 2:812-819.
27. Hubner S., Xiao C.Y., Jans D.A. The protein kinase CK2 site (Ser111/112) enhances recognition of the simian virus 40 large T-antigen nuclear localization sequence by importin. J. Biol. Chem. 1997, 272:17191-17195.
28. Alvisi G., Ripalti A., Ngankeu A., Giannandrea M., Caraffi S.G., Dias M.M., Jans D.A. Human cytomegalovirus DNA polymerase catalytic subunit pUL54 possesses independently acting nuclear localization and pp UL44 binding motifs. Traffic 2006, 7:1322-1332.
29. Kuusisto H.V., Wagstaff K.M., Alvisi G., Jans D.A. The C-terminus of apoptin represents a unique tumor cell-enhanced nuclear targeting module. Int. J. Cancer 2008, 123:2965-2969.
30. Poon I.K., Oro C., Dias M.M., Zhang J., Jans D.A. Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res. 2005, 65:7059-7064.
31. Yashiroda Y., Yoshida M. Nucleo-cytoplasmic transport of proteins as a target for therapeutic drugs. Curr. Med. Chem. 2003, 10:741-748.
32. Ng I.H., Ng D.C., Jans D.A., Bogoyevitch M.A. Selective STAT3-alpha or -beta expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes. Biochem. J. 2012, 447:125-136.
33. Decker T., Kovarik P. Serine phosphorylation of STATs. Oncogene 2000, 19:2628-2637.
34. Sun G., Kemble D.J. To C or not to C: direct and indirect redox regulation of Src protein tyrosine kinase. Cell Cycle 2009, 8:2353-2355.
35. Shields B.J., Wiede F., Gurzov E.N., Wee K., Hauser C., Zhu H.J., Molloy T.J., O'Toole S.A., Daly R.J., Sutherland R.L., Mitchell C.A., McLean C.A., Tiganis T. TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers. Mol. Cell. Biol. 2013, 33:557-570.
36. Yi T., Lindner D. The role and target potential of protein tyrosine phosphatases in cancer. Curr. Oncol. Rep. 2008, 10:114-121.
37. Blanchetot C., Tertoolen L.G., den Hertog J. Regulation of receptor protein-tyrosine phosphatase alpha by oxidative stress. EMBO J. 2002, 21:493-503.
38. Wakahara R., Kunimoto H., Tanino K., Kojima H., Inoue A., Shintaku H., Nakajima K. Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45. Genes Cells 2012, 17:132-145.
39. Yamamoto T., Sekine Y., Kashima K., Kubota A., Sato N., Aoki N., Matsuda T. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem. Biophys. Res. Commun. 2002, 297:811-817.
40. Huang S., Chang I.S., Lin W., Ye W., Luo R.Z., Lu Z., Lu Y., Zhang K., Liao W.S., Tao T., Bast R.C., Chen X., Yu Y. ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins. Biosci. Rep. 2010, 30:159-168.
41. Cimica V., Chen H.C., Iyer J.K., Reich N.C. Dynamics of the STAT3 transcription factor: nuclear import dependent on Ran and importin-beta1. PLoS One 2011, 6:e20188.
42. Liu L., McBride K.M., Reich N.C. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8150-8155.
43. Ushijima R., Sakaguchi N., Kano A., Maruyama A., Miyamoto Y., Sekimoto T., Yoneda Y., Ogino K., Tachibana T. Extracellular signal-dependent nuclear import of STAT3 is mediated by various importin alphas. Biochem. Biophys. Res. Commun. 2005, 330:880-886.
44. Carballo M., Conde M., El Bekay R., Martin-Nieto J., Camacho M.J., Monteseirin J., Conde J., Bedoya F.J., Sobrino F. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J. Biol. Chem. 1999, 274:17580-17586.
45. Bito T., Sumita N., Masaki T., Shirakawa T., Ueda M., Yoshiki R., Tokura Y., Nishigori C. Ultraviolet light induces Stat3 activation in human keratinocytes and fibroblasts through reactive oxygen species and DNA damage. Exp. Dermatol. 2010, 19:654-660.
46. Kodiha M., Chu A., Matusiewicz N., Stochaj U. Multiple mechanisms promote the inhibition of classical nuclear import upon exposure to severe oxidative stress. Cell Death Differ. 2004, 11:862-874.
47. Miyamoto Y., Saiwaki T., Yamashita J., Yasuda Y., Kotera I., Shibata S., Shigeta M., Hiraoka Y., Haraguchi T., Yoneda Y. Cellular stresses induce the nuclear accumulation of importin alpha and cause a conventional nuclear import block. J. Cell Biol. 2004, 165:617-623.
48. Crampton N., Kodiha M., Shrivastava S., Umar R., Stochaj U. Oxidative stress inhibits nuclear protein export by multiple mechanisms that target FG nucleoporins and Crm1. Mol. Biol. Cell 2009, 20:5106-5116.
49. Yasuda Y., Miyamoto Y., Saiwaki T., Yoneda Y. Mechanism of the stress-induced collapse of the Ran distribution. Exp. Cell Res. 2006, 312:512-520.
50. Lee J.L., Wang M.J., Chen J.Y. Acetylation and activation of STAT3 mediated by nuclear translocation of CD44. J. Cell Biol. 2009, 185:949-957.
51. Kermorgant S., Parker P.J. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J. Cell Biol. 2008, 182:855-863.
52. Sehgal P.B. Paradigm shifts in the cell biology of STAT signaling. Semin. Cell Dev. Biol. 2008, 19:329-340.
53. Bild A.H., Turkson J., Jove R. Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. EMBO J. 2002, 21:3255-3263.
54. Imamoto N., Kose S. Heat-shock stress activates a novel nuclear import pathway mediated by Hikeshi. Nucleus 2012, 3:422-428.
55. Kose S., Furuta M., Imamoto N. Hikeshi, a nuclear import carrier for Hsp70s, protects cells from heat shock-induced nuclear damage. Cell 2012, 149:578-589.
56. Kodiha M., Stochaj U. Nuclear transport: a switch for the oxidative stress-signaling circuit?. J. Signal Transduct. 2012, 2012:208650.
57. Huang Y., Qiu J., Dong S., Redell M.S., Poli V., Mancini M.A., Tweardy D.J. Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end. J. Biol. Chem. 2007, 282:34958-34967.
58. Bournazou E., Bromberg J. Targeting the tumor microenvironment: JAK-STAT3 signaling. JAK-STAT 2013, 2:e23828.
59. Sansone P., Bromberg J. Targeting the interleukin-6/Jak/stat pathway in human malignancies. J. Clin. Oncol. 2012, 30:1005-1014.
60. Filosto S., Khan E.M., Tognon E., Becker C., Ashfaq M., Ravid T., Goldkorn T. EGF receptor exposed to oxidative stress acquires abnormal phosphorylation and aberrant activated conformation that impairs canonical dimerization. PLoS One 2011, 6:e23240.